{"entity":{"id":"gc-genome","kind":"company","name":"GC Genome","aka":[],"tldr":"A South Korean genetic testing company that sells ai-CANCERCH, a blood test for several cancers based on DNA fragment patterns.","summary":"GC Genome launched ai-CANCERCH in September 2023 for six cancers, built on whole-genome fragmentomics developed with KAIST (Nature Communications 2023), and announced in November 2025 a planned expansion to ten.","asOf":"2026-10-29","links":[{"label":"Bae et al., Nature Communications 2023","url":"https://doi.org/10.1038/s41467-023-37768-3"}],"tags":[],"related":[],"cancers":[],"sections":["early-detection","diagnostics"],"technologies":["mced","liquid-biopsy","fragmentomics"],"targets":[],"drugs":["ai-cancerch"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["The company's website could not be confirmed on 29 October 2026; the launch and expansion dates are the company's own, from its 27 November 2025 press release."],"hq":"Yongin","country":"KR","companyType":"diagnostics","investors":[],"funding":[]},"route":"/companies/gc-genome/","neighbours":{"section":[{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"},{"id":"early-detection","kind":"section","name":"Early Detection & Screening","route":"/fronts/early-detection/"}],"technology":[{"id":"fragmentomics","kind":"technology","name":"cfDNA fragmentomics","route":"/technologies/fragmentomics/"},{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"},{"id":"mced","kind":"technology","name":"Multi-cancer early detection (MCED)","route":"/technologies/mced/"}],"drug":[{"id":"ai-cancerch","kind":"drug","name":"ai-CANCERCH","route":"/drugs/ai-cancerch/"}]}}